The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Direct Oral Anticoagulant Market Research Report 2024
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Direct Oral Anticoagulant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Direct Oral Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Oral Anticoagulant.
Report Scope
The Direct Oral Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Direct Oral Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Direct Oral Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Segment by Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segment by Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Direct Oral Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Direct Oral Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Direct Oral Anticoagulant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Direct Oral Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Oral Anticoagulant.
Report Scope
The Direct Oral Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Direct Oral Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Direct Oral Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Segment by Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segment by Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Direct Oral Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Direct Oral Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Direct Oral Anticoagulant Market Overview
1.1 Product Overview and Scope of Direct Oral Anticoagulant
1.2 Direct Oral Anticoagulant Segment by Type
1.2.1 Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030)
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Direct Oral Anticoagulant Segment by Application
1.3.1 Global Direct Oral Anticoagulant Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Direct Oral Anticoagulant Market Size Estimates and Forecasts
1.4.1 Global Direct Oral Anticoagulant Revenue 2019-2030
1.4.2 Global Direct Oral Anticoagulant Sales 2019-2030
1.4.3 Global Direct Oral Anticoagulant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Direct Oral Anticoagulant Market Competition by Manufacturers
2.1 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Direct Oral Anticoagulant Average Price by Manufacturers (2019-2024)
2.4 Global Direct Oral Anticoagulant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application
2.7 Direct Oral Anticoagulant Market Competitive Situation and Trends
2.7.1 Direct Oral Anticoagulant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Direct Oral Anticoagulant Players Market Share by Revenue
2.7.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Direct Oral Anticoagulant Retrospective Market Scenario by Region
3.1 Global Direct Oral Anticoagulant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Sales by Region: 2019-2030
3.2.1 Global Direct Oral Anticoagulant Sales by Region: 2019-2024
3.2.2 Global Direct Oral Anticoagulant Sales by Region: 2025-2030
3.3 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Revenue by Region: 2019-2030
3.3.1 Global Direct Oral Anticoagulant Revenue by Region: 2019-2024
3.3.2 Global Direct Oral Anticoagulant Revenue by Region: 2025-2030
3.4 North America Direct Oral Anticoagulant Market Facts & Figures by Country
3.4.1 North America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.4.3 North America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Direct Oral Anticoagulant Market Facts & Figures by Country
3.5.1 Europe Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Direct Oral Anticoagulant Sales by Country (2019-2030)
3.5.3 Europe Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Direct Oral Anticoagulant Market Facts & Figures by Country
3.6.1 Asia Pacific Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Direct Oral Anticoagulant Sales by Country (2019-2030)
3.6.3 Asia Pacific Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country
3.7.1 Latin America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.7.3 Latin America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country
3.8.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Direct Oral Anticoagulant Sales by Type (2019-2030)
4.1.1 Global Direct Oral Anticoagulant Sales by Type (2019-2024)
4.1.2 Global Direct Oral Anticoagulant Sales by Type (2025-2030)
4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2019-2030)
4.2 Global Direct Oral Anticoagulant Revenue by Type (2019-2030)
4.2.1 Global Direct Oral Anticoagulant Revenue by Type (2019-2024)
4.2.2 Global Direct Oral Anticoagulant Revenue by Type (2025-2030)
4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2019-2030)
4.3 Global Direct Oral Anticoagulant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Direct Oral Anticoagulant Sales by Application (2019-2030)
5.1.1 Global Direct Oral Anticoagulant Sales by Application (2019-2024)
5.1.2 Global Direct Oral Anticoagulant Sales by Application (2025-2030)
5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2019-2030)
5.2 Global Direct Oral Anticoagulant Revenue by Application (2019-2030)
5.2.1 Global Direct Oral Anticoagulant Revenue by Application (2019-2024)
5.2.2 Global Direct Oral Anticoagulant Revenue by Application (2025-2030)
5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2019-2030)
5.3 Global Direct Oral Anticoagulant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Meyers Squibb Co
6.1.1 Bristol-Meyers Squibb Co Corporation Information
6.1.2 Bristol-Meyers Squibb Co Description and Business Overview
6.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Portfolio
6.1.5 Bristol-Meyers Squibb Co Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Corporation Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Boehringer Ingelheim Pharmaceuticals, Inc
6.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
6.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
6.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Portfolio
6.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates
6.4 Janssen Pharmaceuticals, Inc.
6.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Portfolio
6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Direct Oral Anticoagulant Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Pab Organics Private Limited
6.6.1 Pab Organics Private Limited Corporation Information
6.6.2 Pab Organics Private Limited Description and Business Overview
6.6.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Portfolio
6.7.5 Pab Organics Private Limited Recent Developments/Updates
6.8 Daiichi Sankyo Company, Limited
6.8.1 Daiichi Sankyo Company, Limited Corporation Information
6.8.2 Daiichi Sankyo Company, Limited Description and Business Overview
6.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Portfolio
6.8.5 Daiichi Sankyo Company, Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Direct Oral Anticoagulant Industry Chain Analysis
7.2 Direct Oral Anticoagulant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Direct Oral Anticoagulant Production Mode & Process
7.4 Direct Oral Anticoagulant Sales and Marketing
7.4.1 Direct Oral Anticoagulant Sales Channels
7.4.2 Direct Oral Anticoagulant Distributors
7.5 Direct Oral Anticoagulant Customers
8 Direct Oral Anticoagulant Market Dynamics
8.1 Direct Oral Anticoagulant Industry Trends
8.2 Direct Oral Anticoagulant Market Drivers
8.3 Direct Oral Anticoagulant Market Challenges
8.4 Direct Oral Anticoagulant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
